SML1391

Olmesartan medoxomil

≥98% (HPLC)

• 别名: 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, CS-866
• 经验公式（希尔记法）: C₂₉H₃₀N₆O₆
• CAS号: 144689-63-4
• 分子量: 558.59
• MDL编号: MFCD00944911
• UNSPSC代码: 12352200
• PubChem化学物质编号: 329825839
• NACRES: NA.77

属性

• 质量水平: 100
• 方案: ≥98% (HPLC)
• 表单: powder
• 颜色: white to beige
• 溶解性: DMSO: 10 mg/mL, clear
• 储存温度: 2-8°C
• SMILES字符串: CCCC1=NC(C(O)(C)C)=C(C(OCC2=C(C)OC(O2)=O)=O)N1CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5
• InChI: 1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)
• InChI key: UQGKUQLKSCSZGY-UHFFFAOYSA-N
• 基因信息: human ... AGTR1(185)

说明

生化/生理作用

Olmesartan medoxomil is a selective Angiotensin II Type I receptor blocker and antihypertensive drug. Olmesartan medoxomil is converted enzymatically to the active form olmesartan.

Olmesartan medoxomil is considered as an antihypertensive agent. It is an angiotensin 2 type 1 antagonist receptor.[1] It is a prodrug which releases the parent compound olmesartan after ingestion. Olmesartan is ejected via kidney and liver.[2] In humans, olmesartan protects renal and cardiovascular systems. This drug may be used in the treatment of hypertension.[3]

安全信息

• 象形图: GHS07
• 警示用语：: Warning
• 危险声明: H302 + H312 + H332
• 预防措施声明: P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312
• 危险分类: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
• 储存分类代码: 11 - Combustible Solids
• WGK: WGK 3
• 闪点(°F): Not applicable
• 闪点(°C): Not applicable